Roche Holding AG's arthritis and cancer drug, Rituxan, received approval from the U.S. Food and Drug Administration (FDA) to treat two rare disorders that cause blood vessel inflammation.
During an interview with 60 minutes, Microsoft co-founder Paul Allen Allen talks about the early days of Microsoft, his battles with cancer, and what it was like to be made miserable by the richest man in the world.
Microsoft co-founder Paul Allen won't apologize for his unabashed criticism of former best friend and co-founder Bill Gates.
Catherine Zeta-Jones follows several celebrities including Ben Stiller and Sting into treatment for Bipolar Disorder. The actress was reportedly hit by the stress of husband Michael Douglas' throat cancer battle.
People.com is reporting that actress Catherine Zeta-Jones was treated for Bipolar Disorder.
Former Libyan strongman Moussa Koussa, who is strongly believed to have played a role in the infamous Lockerbie bombing, was allowed to leave London on Tuesday. Britain's coalition government has been accused of offering a transit lounge for alleged war criminals after a foreign office spokesperson said Koussa was free to come and go.
A U.S. Environmental Protection Agency draft assessment of the potential health effects associated with formaldehyde exposure needs substantial revision, says a new report from the National Research Council, which recommends improvements for EPA's final assessment.
Japanese Nuclear and Industrial Safety Agency (NISA) said it has raised the accident levels at Fukushima Daiichi Nuclear power plant to level 7 Major Accident.
The top after-market NASDAQ Stock Market gainers are: Exelixis, KIT digital, Tibco Software, Layne Christensen, and Schnitzer Steel Industries. The top after-market NASDAQ Stock Market losers are: Micrel, Extreme Networks, TranS1, Lionbridge Technologies, and NPS Pharmaceuticals.
The Beastie Boys are making a comeback by releasing a single, an album and a movie trailer publicizing the album.
The authorized biography of Apple CEO Steve Jobs is set to be published early next year.
President Barack Obama and House Speaker John Boehner spoke for several minutes without reaching a resolution early Friday evening, a Republican aide said extending a day of delay on averting a federal shutdown by midnight.
Leaders of the House and Senate were at odds on Friday over the reasons for not reaching agreement about funding the federal government for the next six months to avert a federal shutdown by midnight as spending cuts and federal funding for the women's health organization emerged as key sticking points.
Shares of Immunogen Inc. (NASDAQ: IMGN) touched a new 52-week high and a 9-year high of $12.03 on Thursday. Roche Holding AG said an experimental drug T-DM1 was effective in a mid-stage study of breast cancer patients whose disease has spread.
Reports have surfaced that Matt Lauer, host of the Today show will step down from his position at the NBC morning show.
British pharmaceutical giant AstraZeneca Plc said the U.S. Food and Drug Administration (FDA) cleared its orphan drug vandetanib to treat advanced cases of a thyroid cancer.
Rumors are circulating the Internet Wednesday morning that Meredith Vieira will be leaving NBC and the “Today” show.
A European Space Agency satellite has measured record low levels of ozone over the Arctic, creating a situation similar to the ozone hole over the Antarctic.
Moussa Koussa, the former foreign minister of Libya who recently defected to the United Kingdom, may soon be answering questions about the tragic Lockerbie bombing of December 1988, according to Scottish prosecutors.
The U.S. Court of Appeals for the Federal Circuit heard arguments today that could decide the future of the biotech industry, in a case over whether genes can be patented.
The top pre-market NASDAQ Stock Market gainers are: McCormick & Schmick's Seafood Restaurants, VIVUS, Orexigen Therapeutics, Star Scientific, and Optimer Pharmaceuticals. The top pre-market NASDAQ Stock Market losers are: OmniVision Technologies, DepoMed, TD AMERITRADE Holding, Logitech International, and Check Point Software Technologies.
The top pre-market NASDAQ Stock Market gainers are: Synthesis Energy Systems, Tesla Motors, Randgold Resources, Dendreon, and Clean Energy Fuels. The top pre-market NASDAQ Stock Market losers are: Sinovac Biotech, OpenTable, Apollo Group, SciQuest, and NXP Semiconductors.
